Clinical Trials Directory

Trials / Completed

CompletedNCT03764891

Clinical Outcomes of Transvaginal Mesh Procedures for Cystocele Repair: Comparisons of Uphold and Perigee Systems

Far Eastern Memorial Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
152 (actual)
Sponsor
Far Eastern Memorial Hospital · Academic / Other
Sex
Female
Age
20 Years
Healthy volunteers
Not accepted

Summary

Pelvic organ prolapse (POP) is a major health concern, affecting more than 30% of women. The aim of this study was to compare the clinical outcomes of Uphold system and Perigee system in treating women with cystocele.

Detailed description

Pelvic organ prolapse (POP) is a major health concern, affecting more than 30% of women. Traditional vaginal surgery with native tissue is associated with high recurrence rate. Thus, synthetic meshes were introduced into POP surgery and became the mainstream. Several transvaginal mesh procedures, such as Uphold system (Boston Scientific) and Perigee system (American Medical Systems Inc), have been used for cystocele repair. Perigee system is a trans-obturator four-arm mesh device attached to proximal and distal arcus tendineus fasciae pelvis. Nonetheless, Uphold system, is a single incised, two-arm anterior sacrospinous mesh fixation system. Both systems can be used for cystocele repair, despite Uphold system can be used for concomitant repair of apical prolapse. The aim of this study was to compare the clinical outcomes of Uphold system and Perigee system in treating women with cystocele.

Conditions

Interventions

TypeNameDescription
PROCEDUREUpholdUphold system in treating women with cystocele
PROCEDUREPerigeePerigee system in treating women with cystocele

Timeline

Start date
2018-11-02
Primary completion
2020-04-28
Completion
2020-07-30
First posted
2018-12-05
Last updated
2023-09-15

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03764891. Inclusion in this directory is not an endorsement.